新生儿颅内出血后脑积水的治疗方法评价

摘要/Abstract

摘要：

　早产儿颅内出血发生率较过去30年有明显降低，但随着超早早产儿存活数量的增多，严重颅内出血继发脑积水成为早产儿管理中的棘手问题之一。颅内出血后脑积水的治疗方法包括，反复腰椎穿刺放液、通过脑室储液囊反复放液、脑室-腹腔分流术、引流加灌洗和纤维溶解综合治疗、应用利尿剂减少脑脊液产生、脑室内纤维溶解治疗等。文章阐述颅内出血后脑积水的病理生理机制、不同干预措施的指征及其效果和安全性等。

Abstract: Although the percentage of preterm infants developing intraventricular haemorrhage (IVH) has been greatly reduced in the past three decades, increased survival of extremely preterms has meant that severe IVH with subsequent posthae-morrhagic hydrocephalus is still one of the serious unsolved problems for managements of preterms. Therapeutic interventions for posthaemorrhagic hydrocephalus include serial lumbar punctures, repeated aspiration through a ventricular access device, ventriculoperitoneal shunting, drainage, irrigation and fibrinolytic therapy, diuretic therapy treatment to reduce cerebrospinal fluid production, intraventricular fibrinolytic therapy, etc. This review summarizes the current concepts on the pathophysiology, intervention indications, and the effectiveness and safety of different interventions of subsequent posthaemorrhagic hydrocephalus.

俞丽君，林振浪. 新生儿颅内出血后脑积水的治疗方法评价[J]. 临床儿科杂志, 2014, 32(3): 201-205.

YU Lijun,LIN Zhenlang . Evaluation of the therapies for neonatal posthaemorrhagic hydrocephalus　[J]. , 2014, 32(3): 201-205.

参考文献

[1] Robinson S. Neonatal posthemorrhagic hydrocephalus from prematurity：pathophysiology and current treatment concepts [J]. J Neurosurg Pediatr，2012，9(3)：242-258.
[2] Savman K，Nilsson UA，Blennow M，et al. Non-protein-bound iron is elevated in cerebrospinal fluid from preterm infants with posthemorrhagic ventricular dilatation [J]. Pediatr Res，2001，49(2)：208-212.
[3] Perrone S，Tataranno ML，Negro S，et al. Early identification of the risk for free radical-related diseases in preterm newborns [J]. Early Hum De，2010，86(4)：241-244.
[4] Schmitz T，Heep A，Groenendaal F，et al. Interleukin-1 beta，interleukin-18，and interferon-gamma expression in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus--markers of white matter damage? [J]. Pediatr Res，2007，61(6)：722-726.
[5] Whitelaw A，Christie S，Pople I. Transforming growth factor-beta1：a possible signal molecule for posthemorrhagic hydrocephalus? [J]. Pediatr Res，1999，46(5)：576-580.
[6] Cherian S，Whitelaw A，Thoresen M，et al. The pathogenesis of neonatal post-hemorrhagic hydrocephalus [J]. Brain Pathol，2004，14(3)：305-311.
[7] Flood C，Akinwunmi J，Lagord C，et al. Transforming growth factor-beta1 in the cerebrospinal fluid of patients with subarachnoid hemorrhage：titers derived from exogenous and endogenous sources [J]. J Cereb Blood Flow Metab，2001，21(2)：157-162.
[8] Yung YC，Mutoh T，Lin ME，et al. Lysophosphatidic acid signaling may initiate fetal hydrocephalus [J]. Sci Transl Med，2011，3(99)：99ra87.
[9] Kaiser AM，Whitelaw AG. Cerebrospinal fluid pressure during post haemorrhagic ventricular dilatation in newborn infants [J]. Arch Dis Child，1985，60(10)：920-924.
[10] Fenton TR. A new growth chart for preterm babies：Babson and Benda's chart updated with recent data and a new format [J]. BMC Pediatr，2003，3：13.
[11] Fenton TR，Sauve RS. Using the LMS method to calculate z-scores for the Fenton preterm infant growth chart [J]. Eur J Clin Nutr，2007，61(12)：1380-1385.
[12] Levene MI. Measurement of the growth of the lateral ventricles in preterm infants with real-time ultrasound [J]. Arch Dis Child，1981，56(12)：900-904.
[13] Davies MW，Swaminathan M，Chuang SL，et al. Reference ranges for the linear dimensions of the intracranial ventricles in preterm neonates [J]. Arch Dis Child Fetal Neonatal Ed，2000，82(3):F218-F223.
[14] Whitelaw A，Aquilina K. Management of posthaemorrhagic ventricular dilatation [J]. Arch Dis Child Fetal Neonatal Ed，2012，97(3)：F229-F223.
[15] Kreusser KL，Tarby TJ，Kovnar E，et al. Serial lumbar punctures for at least temporary amelioration of neonatal posthemorrhagic hydrocephalus [J]. Pediatrics，1985，75(4)：719-724.
[16] Whitelaw A. Repeated lumbar or ventricular punctures in newborns with intraventricular hemorrhage [J]. Cochrane Database Syst Rev，2001，(1)：CD000216.
[17] de Vries LS，Liem KD，van DK，et al. Early versus late treatment of posthaemorrhagic ventricular dilatation：results of a retrospective study from five neonatal intensive care units in the Netherlands [J]. Acta Paediatr，2002，91(2)：212-217.
[18] van Alfen-van der Velden AA，Hopman JC，Klaessens JH，et al. Cerebral hemodynamics and oxygenation after serial CSF drainage in infants with PHVD [J]. Brain Dev，2007，29(10):623-629.
[19] Brouwer A，Groenendaal F，van Haastert IL，et al. Neurodevelopmental outcome of preterm infants with severe intraventricular hemorrhage and therapy for posthemorrhagic ventri-cular dilatation [J]. J Pediatr，2008，152(5):648-654.
[20] Brouwer AJ，van Stam C，Uniken Venema M，et al.Cognitive and neurological outcome at the age of 5-8 years of preterm infants with post-hemorrhagic ventricular dilatation requi-ring neurosurgical intervention [J]. Neonatology，2012，101(3):210-216.
[21] 林振浪，余波，梁志强，等. 新生儿脑室出血后脑积水储液囊埋植引流治疗15例分析 [J].中华儿科杂志，2009，47(2):140-145.
[22] 林坚，林振浪，尹波，等. Ommaya 储液囊在儿童急性梗阻性脑积水中的应用 [J].中华小儿外科杂志，2011，32(5):330-332.
[23] Brouwer AJ，Groenendaal F，van den Hoogen A，et al. Incidence of infections of ventricular reservoirs in the treatment of post-haemorrhagic ventricular dilatation：a retrospective study (1992-2003) [J]. Arch Dis Child Fetal Neonatal Ed，2007，92(1)：F41-F43.
[24] 余梦楠，黄柳明，刘刚，等. Ommaya 囊埋植治疗早产儿脑室内出血后脑积水实施中的管理 [J]. 中国新生儿科杂志，2013，28(1):36-38.
[25] Jian L，Hang-song S，Zheng-Lang L，et al. Implantation of Ommaya reservoir in extremely low weight premature infants with posthemorrhagic hydrocephalus：a cautious option [J]. Childs Nerv Syst，2012，28(10):1687-1691.
[26] Kennedy CR，Ayers S，Campbell MJ，et al. Randomized，controlled trial of acetazolamide and furosemide in posthemorrhagic ventricular dilation in infancy：follow-up at 1 year [J]. Pediatrics，2001，108(3):597-607.
[27] Pang D，Sclabassi RJ，Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model：Part 3. Effects of intraventricular urokinase on clot lysis and posthemorrha-gic hydrocephalus [J]. Neurosurgery，1986，19(4)：553-572.
[28] Whitelaw A，Evans D，Carter M，et al. Randomized clinical trial of prevention of hydrocephalus after intraventricular hemorrhage in preterm infants：brain-washing versus tapping fluid [J]. Pediatrics，2007，119(5)：e1071-e1078.
[29] Whitelaw A，Pople I，Cherian S，et al. Phase 1 trial of prevention of hydrocephalus after intraventricular hemorrhage in newborn infants by drainage，irrigation，and fibrinolytic the-rapy [J]. Pediatrics，2003，111(4 Pt 1)：759-765.
[30] Whitelaw A，Jary S，Kmita G，et al. Randomized trial of drai-nage，irrigation and fibrinolytic therapy for premature infants with posthemorrhagic ventricular dilatation：developmental outcome at 2 years [J]. Pediatrics，2010，125(4)：e852-e858.
[31] Hislop JE，Dubowitz LM，Kaiser AM，et al. Outcome of infants shunted for post-haemorrhagic ventricular dilatation [J]. Dev Med Child Neurol，1988，30(4)：451-456.
[32] Willis B，Javalkar V，Vannemreddy P，et al. Ventricular reservoirs and ventriculoperitoneal shunts for premature infants with posthemorrhagic hydrocephalus：an institutional expe-rience [J]. J Neurosurg Pediatr，2009，3(2)：94-100.
[33] Srinivasakumar P，Limbrick D，Munro R，et al. Posthemorrhagic ventricular dilatation-impact on early neurodevelopmental outcome [J]. Am J Perinatol，2013，30(3):207-214.
[34] Elgamal EA，El-Dawlatly AA，Murshid WR，et al. Endoscopic third ventriculostomy for hydrocephalus in children younger than 1 year of age [J]. Childs Nerv Syst，2011，27(1)：111-116.
[35] Bhandari V，Buhimschi CS，Han CS，et al. Cord blood erythropoietin and interleukin-6 for prediction of intraventricular hemorrhage in the preterm neonate [J]. J Matern Fetal Neonatal Med，2011，24(5)：673-679.
[36] Rees S，Hale N，De Matteo R，et al. Erythropoietin is neuroprotective in a preterm ovine model of endotoxin-induced brain injury [J]. J Neuropathol Exp Neurol，2010，69(3)：306-319.
[37] Pimentel-Coelho PM，Mendez-Otero R. Mendez-Otero. Cell therapy for neonatal hypoxic-ischemic encephalopathy [J]. Stem Cells Dev，2010，19(3)：299-310.
[38] Donega V，van Velthoven CT，Nijboer CH，et al. Intranasal mesenchymal stem cell treatment for neonatal brain damage：long-term cognitive and sensorimotor improvement [J]. PLoS One，2013，8(1)：e51253.